Definitive Contract 75N91024C00050
Award Date
9/15/24
Potential Completion Date
3/14/27
Potential Value
$625K
Federal Agency
National Cancer Institute
Awardee
The General Hospital Corporation
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02114, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit hospital and research institution. The $249,997.00 contract will obtain data on a cohort of pediatric cancer patients treated with proton therapy and a comparison group treated with photon therapy, to serve as part of a...
The National Institutes of Health's National Cancer Institute awarded a $249,323 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital. This contract is to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. Per the statement of work, the center will coordinate data collection and analysis from multiple pediatric cancer treatment sites comparing outcomes of patients...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit 999-bed medical center affiliated with Harvard Medical School. The $249,998.00 contract is for MGH to develop and manage online data platforms that mirror existing platforms used in the Pediatric Proton Comparison Registry (PPCR) for the acquisition...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $248,045 firm fixed price purchase order to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit 999-bed medical center affiliated with Harvard Medical School. The contract is for data acquisition and management services to provide training, technical assistance, and supervisory management to operate a coordinating center for the...
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing...
This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI) to Princeton Procure Management LLC (Procure Proton Center) for $150,150 to provide medical record abstraction services for a study comparing pediatric proton and photon radiotherapy. The 14-month contract, which starts on or about November 1, 2024, is part of NCI's Pediatric Proton and Photon Therapy Comparison Cohort program. The contractor will retrieve de-identified clinical and treatment data from medical...
The National Cancer Institute (NCI) awarded a $249,814 firm fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to establish the US Pediatric Proton and Photon Therapy Cohort. This retrospective cohort study will compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
This is a $250,000.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Baylor College of Medicine for the US Pediatric Proton and Photon Therapy Cohort study. The contract, which has no set-aside designation, requires Baylor to retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric cancer patients treated with proton or photon therapy at their institution. This data will be used to evaluate the risks and benefits of...
The U.S. National Aeronautics and Space Administration (NASA) awarded a $75,100.00 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), for laser beam time at the MGH Burr Proton Therapy Center. This contract is not set-aside and has an ultimate completion date of December 30, 2024. MGH is a 999-bed medical center and the primary teaching hospital of Harvard Medical School, conducting extensive...